期刊文献+

Danon病所致肥厚性心肌病LAMP2基因新突变分析 被引量:1

A case of hypertrophic cardiomyopathy due to Danon disease and a novel mutation on LAMP2 gene
原文传递
导出
摘要 目的分析以肥厚性心肌病为主要表现的Danon病患儿临床及LAMP2基因突变检测结果。方法 2013年10月北京大学第一医院儿科收治的1例3岁男性儿童(先证者),以肥厚性心肌病为主要表现,为明确病因进行了临床调查及基因分析。结果患儿(先证者)智力运动及体格发育正常,入托体检发现肝酶异常。血清丙氨酸氨基转移酶、天冬氨酸氨基转移酶、肌酸激酶、肌酸激酶同工酶、乳酸脱氢酶、羟丁酸脱氢酶升高。心电图显示左室高电压,Q-T间期延长。超声心动图显示室间隔及左室壁增厚,左室心尖部肌小梁增多,二尖瓣关闭不全,符合肥厚性心肌病诊断。LAMP2基因分析显示:患儿存在c.973-974insC(p.L325fs)纯合突变。母亲患不明原因的肥厚性心肌病,为c.973-974insC杂合突变携带者。其父亲健康,LAMP2基因正常。c.973-974insC为新发现突变,导致框移突变,并产生1个提前终止翻译的密码子。结论 Danon病是一种少见的致死性遗传性心肌病,本文通过基因检测确诊了中国首例Danon病患者。LAMP2基因分析不仅有助于诊断Danon病,对于指导家系遗传咨询及产前诊断至关重要。 Objectives To investigate the clinical features and LAMP2 gene mutation a case with hypertrophic cardiomyopathy due to Danon disease. Methods A boy (proband) of hypertrophic cardiomyopathy due to Danon disease was hospitalized in the Department of Pediatrics of Peking University First Hospital on October, 2013. He was the first child of non-consanguineous Chinese couples. Gene analysis was performed by direct sequencing. Results The patient had not any symptoms with normal intelligence and physical development. Elevated serum alanine aminotransferase had been noticed in a medical examination for entry to kindergarten. His serum alanine aminotransferase, glutamic-oxaloacetic transaminase, creatine phosphokinase, creatine kinase-MB, lactate dehydrogenase, and hydroxybutyrate dehydrogenase were elevated. Electrocardiograph showed left ventricular high voltage, prolonged Q-T interval Ultrasonic cardiogram showed ventricular septum and left ventricular wall thickening, left ventricular enlargement, increased trabecular of left ventrieular apex, and mitral inadequacy, supporting the diagnosis of hypertrophic cardiomyopathy. A homozygous mutation, c.973-974insC (p.L325fs) was detected on LAMP2 gene of the patient. His mother had unexplained hypertrophic cardiomyopathy. She carries a heterozygous mutation c.973-974insC. His father is healthy without any mutation on LAMP2. c.973-974insC was a novel mutation, leading to frameshift mutation and a premature termination codon. Conclusions Danon disease is a rare fatal genetic cardiomyopathy without effective treatment. In this study, a Chinese boy and his mother with Danon disease were firstly diagnosed by gene analysis. LAMP2 gene study is important for the diagnosis of Danon disease and genetic counseling of the family.
出处 《中国实用儿科杂志》 CSCD 北大核心 2014年第10期746-749,共4页 Chinese Journal of Practical Pediatrics
基金 "十二五"国家科技支撑计划项目(2012BAI09B04)
关键词 溶酶体病 Danon病 LAMP2基因 肥厚性心肌病 lysosome disease Danon disease LAMP2 gene hypertrophic cardiomyopathy
  • 相关文献

参考文献10

  • 1Sugie K,Noguchi S,Kozuka Y,et al.Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies[J].Neuropath Exp Neurol,2005,64:513-522. 被引量:1
  • 2何继强,王妍,孟岩,陈琳,姜腾勇.基因诊断为Danon病患者的临床特征分析[J].中华心血管病杂志,2013,41(7):594-597. 被引量:7
  • 3Sabourdy F,Michelakakis H,Anastasakis A,et al.Danon disease:further clinical and molecular heterogeneity[J].Muscle Nerve,2009,39 (6):837-844. 被引量:1
  • 4Eskelinen EL,Cuervo AM,Taylor MR,et al.Unifying nomenclature for the isoforms of the lysosomal membrane protein LAMP-2[J].Traffic,2005,6(11):1058-1061. 被引量:1
  • 5蔡迟,樊朝美.Danon病临床研究进展[J].心血管病学进展,2012,33(1):39-42. 被引量:8
  • 6Beertsen W,Willenborg M,Everts V,et al.Impaired phagosomal maturation in neutrophils leads to periodontitis in lysosomal-associated membrane protein-2 knock-out mice[J].J Immunol,2008,180(1): 475-482. 被引量:1
  • 7Lobrinus JA, Schorderet DF, Payot M, et al. Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease)[J]. Neuromuscul Disord,2005,15:293-298. 被引量:1
  • 8洪道俊,石志鸿,张巍,王朝霞,袁云.溶酶体相关膜蛋白2基因新突变导致Danon病的临床病理特点[J].中华神经科杂志,2010,43(10):707-711. 被引量:6
  • 9Dougu N, John S, Shan L, et al. Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy[J].Circ J,2009,73:376-380. 被引量:1
  • 10Echaniz-Laguna A,Mohr M,Epailly E,et al. Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease [J].Muscle Nerve,2006,33(3):393-397. 被引量:1

二级参考文献52

  • 1陈琳,郭玉璞,任海涛,赵燕环,关鸿志,管宇宙,彭斌,刘大为.少年起病的Ⅱ型糖原累积病五例临床病理研究[J].中华神经科杂志,2005,38(1):51-54. 被引量:16
  • 2Nishino I, Fu J, Tanji K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy ( Danon disease). Nature, 2000, 406:906-910. 被引量:1
  • 3Ruivo R, Anne C, Sagne C, et al. Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochim Biophys Acta, 2009, 1793:636-649. 被引量:1
  • 4Konecki DS, Foetisch K, Zimmer KP, et al. An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner. Biochem Biophys Res Commun, 1995, 215:757-767. 被引量:1
  • 5Maron B J, Roberts WC, Arad M, et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA, 2009, 301 : 1253-1259. 被引量:1
  • 6Sabourdy F, Michelakakis H, Anastasakis A, et al. Danon disease: further clinical and molecular heterogeneity. Muscle Nerve, 2009, 39:837-844. 被引量:1
  • 7Sugie K, Yamamoto A, Murayama K, et al. Clinicopathological features of genetically confirmed Danon disease. Neurology, 2002, 58 : 1773-1778. 被引量:1
  • 8Lobrinus JA, Schorderet DF, Payot M, et al. Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease). Neuromuscul Disord, 2005, 15:293- 298. 被引量:1
  • 9Schorderet DF, Cottet S, Lobrinus JA, et al. Retinopathy in Danon disease. Arch Ophthalmol, 2007, 125:231-236. 被引量:1
  • 10Tunon T, Guerrero D, Urchaga A, et al. Danon disease: a novel Lamp-2 gene mutation in a family with four affected members. Neuromuscul Disord, 2008, 18 : 167-174. 被引量:1

共引文献16

同被引文献13

  • 1Barth PG,Scholte HR, Berden JA, et al. An X-linkedmitochondrial disease affecting cardiac muscle, skeletal muscleand neutrophil leucocytes[J]. J Neurol Sci,1983,62(1-3) :327-355. 被引量:1
  • 2Zapala B, Platek T,Wybr ariska I. A novel TAZ genemutation and mosaicism in a Polish family with Barth syndrome[J]. Ann Hum Genet,2015 ,79(3) :218-224. 被引量:1
  • 3Roberts AE, Nixon C, Steward CG .etal. The Barth syndromeregistry; distinguishing disease characteristics and growth datafrom a longitudinal study[J], Am J Med Genet A,2012,158A(11):2726-2732. 被引量:1
  • 4Nugent AW, Daubeney PE, Chondros P, et al. Theepidemiology of childhood cardiomyopathy in Australia [J]. NEngl J Med,2003,348(17):1639-1646. 被引量:1
  • 5Kimura M, Yamamoto T,Yamaguchi S. A personal computer-based system for interpretation of gas chromatography massspectrometry data in the diagnosis of organic acidaemias[J].Ann Clin Biochem,1999,36(Pt 5) :671-672. 被引量:1
  • 6Fu X, Iga M, Kimura M, et al. Simplified screening fororganic acidemia using GC/MS and dried urine filter paper: astudy on neonatal mass screening[J]. Early Hum Dev,2000,58(1):41-55. 被引量:1
  • 7Johnston J, Kelley RI, Feigenbaum A,et al. Mutationcharacterization and genotype-phenotype correlation in Barthsyndrome[J]. Am J Hum Genet,1997,61(5) : 1053-1058. 被引量:1
  • 8Acehan D, VazF,Houtkooper RH,et al. Cardiac and skeletalmuscle defects in a mouse model of human Barth syndrome[J].J Biol Chem,2011,286(2) :899-908. 被引量:1
  • 9Liu Q,Qi XF, Ye F,et al. Lack of mutations of G4. 5 in threefamilies from China with noncompaction of the ventricularmyocardium[J], Genet Mol Res,2013,12 (1) : 53-58. 被引量:1
  • 10杨作成.心内膜弹力纤维增生症的诊断与治疗[J].实用儿科临床杂志,2009,24(13):971-973. 被引量:9

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部